Author: Castagna, Alberto; Ruotolo, Giovanni; Manzo, Ciro
Title: Progress in the risk assessment of hydroxychloroquine in frail elderly people Cord-id: vaohwbcz Document date: 2020_12_25
ID: vaohwbcz
Snippet: Hydroxychloroquine (HCQ) is an antimalarial drug also known to have antiâ€inflammatory and antiviral effects. The antiviral action of HCQ has been a point of interest for many researchers because of its mechanism of action and the potential use it could have during the current COVIDâ€19 pandemic. However, HCQ can cause QT interval prolongation. The current therapies used in COVIDâ€19 are changing as the pandemic develops. The aim of this article is to promote a validated risk score for QT pro
Document: Hydroxychloroquine (HCQ) is an antimalarial drug also known to have antiâ€inflammatory and antiviral effects. The antiviral action of HCQ has been a point of interest for many researchers because of its mechanism of action and the potential use it could have during the current COVIDâ€19 pandemic. However, HCQ can cause QT interval prolongation. The current therapies used in COVIDâ€19 are changing as the pandemic develops. The aim of this article is to promote a validated risk score for QT prolongation in multidimensional assessment of COVIDâ€19 patients, especially in elderly and polypathological patients.
Search related documents:
Co phrase search for related documents- acidic environment and liver kidney: 1, 2
- acute coronary syndrome and liver kidney: 1, 2
- acute coronary syndrome and liver kidney disease: 1, 2
- acute respiratory distress syndrome and liver kidney: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64
- acute respiratory distress syndrome and liver kidney disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
Co phrase search for related documents, hyperlinks ordered by date